Skip to main content

Table 5 Unpaired T-test of the quantitative proteomic results for protein expression in the T2DM + LAC group in comparison with the control and T2DM groups

From: Discovery and validation of PZP as a novel serum biomarker for screening lung adenocarcinoma in type 2 diabetes mellitus patients

Protein T2DM + LAC vs. control T2DM + LAC vs. T2DM
Fold change P value Fold change P value
ADIPO −1.873 0.004 −1.629 0.199
CCD87 −1.664  < 0.001 −1.440  < 0.001
CXCL7 −2.700 0.018 −2.245 0.115
FBLN1 −1.506 0.016 −1.372 0.098
FHR1 1.613 0.010 1.510 0.025
FRPD2 −2.097 0.010 −1.751 0.035
HBB −3.534 0.006 −2.188 0.019
HV145 −1.702 0.049 −1.392 0.138
IGFBP3 −1.765 0.044 −2.371 0.003
PZP 1.801 0.023 2.488 0.022
SRGN 1.624 0.038 1.573 0.131
ZN350 −1.679 0.028 −1.810 0.006
  1. LV316 was excluded because of be missing in most samples
\